Technological Innovations in Behavioral Treatments for Cigarette Smoking
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00926939|
Recruitment Status : Completed
First Posted : June 24, 2009
Last Update Posted : April 14, 2015
|Condition or disease||Intervention/treatment||Phase|
|Cigarette Smoking||Behavioral: Reinforcement for the abstinence of smoking Behavioral: Reinforcement for submission of videos with CO sample||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||96 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||Technological Innovations in Behavioral Treatments for Cigarette Smoking|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||May 2014|
|Actual Study Completion Date :||August 2014|
Experimental: Abstinence Contingent (AC)
This group will receive vouchers contingent on smoking reduction and smoking abstinence (confirmed through video submissions). Abstinence is defined as a CO sample of 4ppm or less.
Behavioral: Reinforcement for the abstinence of smoking
Participants in this intervention group will receive vouchers contingent upon a CO sample of 4ppm or less.
Experimental: Submission Contingent (SC)
This group receives vouchers for submitting videos of their CO breath test.
Behavioral: Reinforcement for submission of videos with CO sample
This intervention group will receive vouchers contingent on their submission of videos of their CO breath tests.
- CO sample of ≤ 4ppm [ Time Frame: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention ]
- Participant reporting not smoking, not even a puff in the last 7 days. [ Time Frame: 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention ]
- Twice-daily breath CO samples obtained during treatment period. [ Time Frame: First 4 weeks of treatment ]
- The longest duration of sustained abstinence based on the twice-daily breath samples during the treatment period. [ Time Frame: First 4 weeks of treatment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00926939
|United States, New York|
|National Development and Research Institutes|
|New York City, New York, United States, 10010|
|Principal Investigator:||Jesse Dallery, PhD||National Development and Research Institutes, Inc.|